Arrowhead Pharmaceuticals, Inc.
ARWR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000879407
In the last 90 days, Arrowhead Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 501 institutions reported holding it in 13F filings for Q2 2026, worth $9.73B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Arrowhead Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 274 | 1 | 257 | −16 |
| Shares | 72.4M | 11.7K | 74.6M | +2.30M (+3.2%) |
| Value | $2.57B | $415.7K | $2.01B | −$567.3M (−22.0%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Arrowhead Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Capital International Investors | 822,929 | $22.1M | 0.01% |
| Gsa Capital Partners LLP | 47,527 | $1.28M | 0.11% |
| Comerica Bank | 43,508 | $1.17M | 0.01% |
| Edgestream Partners, L.P. | 41,287 | $1.11M | 0.09% |
| ExodusPoint Capital Management, LP | 32,127 | $863.0K | 0.01% |
| Twinbeech Capital LP | 14,377 | $386.3K | 0.01% |
| Pictet Asset Management Holding SA | 11,656 | $313.2K | 0.00% |
| Man Group plc | – | $291.1K | 0.00% |
| O'Shaughnessy Asset Management, LLC | 9,558 | $256.8K | 0.00% |
| Magnetar Financial LLC | 9,538 | $256.3K | 0.01% |
| Bridgefront Capital, LLC | 9,005 | $242.0K | 0.17% |
| CMH Wealth Management LLC | 8,999 | $241.8K | 0.07% |
| Wealth Enhancement Advisory Services, LLC | 7,771 | $208.8K | 0.00% |
| Quarry LP | 4,955 | $133.1K | 0.09% |
| Highline Wealth Partners LLC | 681 | $18.3K | 0.01% |
| National Bank of Canada | 500 | $13.1K | 0.00% |
| NBC Securities, Inc. | 305 | $8.00K | 0.00% |
| Central Trust Co | 59 | $1.59K | 0.00% |
| FinTrust Capital Advisors, LLC | 37 | $1.00K | 0.00% |
| Annis Gardner Whiting Capital Advisors, LLC | 29 | $780 | 0.00% |
| Bell Investment Advisors, Inc | 17 | $457 | 0.00% |
| Tfo-TDC, LLC | 5 | $178 | 0.00% |
Sold out (38)
Institutions that held Arrowhead Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (1)
Institutions that held Arrowhead Pharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 11,656 | $415.7K |